110 related articles for article (PubMed ID: 10334863)
21. Free fatty acids increase basal hepatic glucose production and induce hepatic insulin resistance at different sites.
Lam TK; van de Werve G; Giacca A
Am J Physiol Endocrinol Metab; 2003 Feb; 284(2):E281-90. PubMed ID: 12531742
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of glucagon secretion.
Young A
Adv Pharmacol; 2005; 52():151-71. PubMed ID: 16492545
[TBL] [Abstract][Full Text] [Related]
23. Hypoglycemic effect of isoleucine involves increased muscle glucose uptake and whole body glucose oxidation and decreased hepatic gluconeogenesis.
Doi M; Yamaoka I; Nakayama M; Sugahara K; Yoshizawa F
Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1683-93. PubMed ID: 17299083
[TBL] [Abstract][Full Text] [Related]
24. Substrates of semicarbazide-sensitive amine oxidase co-operate with vanadate to stimulate tyrosine phosphorylation of insulin-receptor-substrate proteins, phosphoinositide 3-kinase activity and GLUT4 translocation in adipose cells.
Enrique-Tarancón G; Castan I; Morin N; Marti L; Abella A; Camps M; Casamitjana R; Palacín M; Testar X; Degerman E; Carpéné C; Zorzano A
Biochem J; 2000 Aug; 350 Pt 1(Pt 1):171-80. PubMed ID: 10926841
[TBL] [Abstract][Full Text] [Related]
25. Chlorogenic acid and synthetic chlorogenic acid derivatives: novel inhibitors of hepatic glucose-6-phosphate translocase.
Hemmerle H; Burger HJ; Below P; Schubert G; Rippel R; Schindler PW; Paulus E; Herling AW
J Med Chem; 1997 Jan; 40(2):137-45. PubMed ID: 9003513
[TBL] [Abstract][Full Text] [Related]
26. Effects of oxodiperoxovanadate (V) complexes on the activity of green crab (Scylla serrata) alkaline phosphatase.
Zhou XW; Chen QX; Chen Z; He ZQ; Zhou HM
Biochemistry (Mosc); 2000 Dec; 65(12):1424-8. PubMed ID: 11173515
[TBL] [Abstract][Full Text] [Related]
27. Instant coffee extract with high chlorogenic acids content inhibits hepatic G-6-Pase in vitro, but does not reduce the glycaemia.
Bassoli BK; Cassolla P; Borba-Murad GR; Constantin J; Salgueiro-Pagadigorria CL; Bazotte RB; de Souza HM
Cell Biochem Funct; 2015 Jun; 33(4):183-7. PubMed ID: 25959621
[TBL] [Abstract][Full Text] [Related]
28. Compartmentalization and in vivo insulin-induced translocation of the insulin-signaling inhibitor Grb14 in rat liver.
Desbuquois B; Béréziat V; Authier F; Girard J; Burnol AF
FEBS J; 2008 Sep; 275(17):4363-77. PubMed ID: 18657188
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of hepatic glucose 6-phosphatase system by the green tea flavanol epigallocatechin gallate.
Csala M; Margittai E; Senesi S; Gamberucci A; Bánhegyi G; Mandl J; Benedetti A
FEBS Lett; 2007 Apr; 581(8):1693-8. PubMed ID: 17412326
[TBL] [Abstract][Full Text] [Related]
30. Activation of liver G-6-Pase in response to insulin-induced hypoglycemia or epinephrine infusion in the rat.
Bady I; Zitoun C; Guignot L; Mithieux G
Am J Physiol Endocrinol Metab; 2002 Apr; 282(4):E905-10. PubMed ID: 11882511
[TBL] [Abstract][Full Text] [Related]
31. Effects of peroxovanadate and vanadate on insulin binding, degradation and sensitivity in rat adipocytes.
Yu ZW; Posner BI; Smith U; Eriksson JW
Biochim Biophys Acta; 1996 Jan; 1310(1):103-9. PubMed ID: 9244182
[TBL] [Abstract][Full Text] [Related]
32. CS-917, a fructose 1,6-bisphosphatase inhibitor, improves postprandial hyperglycemia after meal loading in non-obese type 2 diabetic Goto-Kakizaki rats.
Yoshida T; Okuno A; Izumi M; Takahashi K; Hagisawa Y; Ohsumi J; Fujiwara T
Eur J Pharmacol; 2008 Dec; 601(1-3):192-7. PubMed ID: 19014931
[TBL] [Abstract][Full Text] [Related]
33. Chlorogenic acid and hydroxynitrobenzaldehyde: new inhibitors of hepatic glucose 6-phosphatase.
Arion WJ; Canfield WK; Ramos FC; Schindler PW; Burger HJ; Hemmerle H; Schubert G; Below P; Herling AW
Arch Biochem Biophys; 1997 Mar; 339(2):315-22. PubMed ID: 9056264
[TBL] [Abstract][Full Text] [Related]
34. Vanadate enhances but does not normalize glucose transport and insulin receptor phosphorylation in skeletal muscle from obese women with gestational diabetes mellitus.
Shao J; Catalano PM; Yamashita H; Ishizuka T; Friedman JE
Am J Obstet Gynecol; 2000 Nov; 183(5):1263-70. PubMed ID: 11084576
[TBL] [Abstract][Full Text] [Related]
35. Bisperoxovanadium complex promotes dopamine exocytosis in PC12 cells.
Bieger S; Morinville A; Maysinger D
Neurochem Int; 2002 Apr; 40(4):307-14. PubMed ID: 11792460
[TBL] [Abstract][Full Text] [Related]
36. The biomimetic [Cr(3)O(O(2)CCH(2)CH(3))(6)(H(2)O)(3)](+ )decreases plasma insulin, cholesterol, and triglycerides in healthy and type II diabetic rats but not type I diabetic rats.
Sun Y; Clodfelder BJ; Shute AA; Irvin T; Vincent JB
J Biol Inorg Chem; 2002 Sep; 7(7-8):852-62. PubMed ID: 12203022
[TBL] [Abstract][Full Text] [Related]
37. Antidiabetic effect of diasulin, a herbal drug, on blood glucose, plasma insulin and hepatic enzymes of glucose metabolism in hyperglycaemic rats.
Pari L; Saravanan R
Diabetes Obes Metab; 2004 Jul; 6(4):286-92. PubMed ID: 15171753
[TBL] [Abstract][Full Text] [Related]
38. Vanadate elevates lipogenicity of starved rat adipose tissue: mechanism of action.
Sekar N; Qian S; Shechter Y
Endocrinology; 1998 May; 139(5):2514-8. PubMed ID: 9564866
[TBL] [Abstract][Full Text] [Related]
39. Selective stimulation of G-6-Pase catalytic subunit but not G-6-P transporter gene expression by glucagon in vivo and cAMP in situ.
Hornbuckle LA; Everett CA; Martin CC; Gustavson SS; Svitek CA; Oeser JK; Neal DW; Cherrington AD; O'Brien RM
Am J Physiol Endocrinol Metab; 2004 May; 286(5):E795-808. PubMed ID: 14722027
[TBL] [Abstract][Full Text] [Related]
40. A novel glucagon receptor antagonist, NNC 25-0926, blunts hepatic glucose production in the conscious dog.
Rivera N; Everett-Grueter CA; Edgerton DS; Rodewald T; Neal DW; Nishimura E; Larsen MO; Jacobsen LO; Kristensen K; Brand CL; Cherrington AD
J Pharmacol Exp Ther; 2007 May; 321(2):743-52. PubMed ID: 17308040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
